Abstract:BACKGROUND: Vaccine-induced antitumor CD8(superscript +) T-cell responses are believed to play an important role in increasing resistance to carcinoma. Research shows that after uptake of fusion proteins of heat-shock protein 70 (HSP70) with tumor associated antigen into antigen presenting cells, processing and representation of heat-shock protein-chaperoned peptides on MHC class I molecules, a CD8(superscript +) cytotoxic T lymphocyte response is initiated. OBJECTIVE: To construct and identify eukaryotic expression vector of melanoma antigen gene 3 MAGE-3-HSP70. DESIGN, TIME AND SETTING: A single sample observation was completed at Key Laboratory of Nano-biotechnology, National Ministry of Health from June to December 2008. MATERIALS: The eukaryotic vector pcDNA3.1 (-) was purchased from BD Company. The vector pINCY/MAGE-3 and pOTB7/HSP70 were purchased from Open Biosystems Company. DH5α were preserved at Key Laboratory of Nano-biotechnology, National Ministry of Public Health, China. METHODS: A pair of MAGE-3 primers containing Xho Ⅰ restriction site and HSP70 primers containing Kpn Ⅰ restriction site were designed. pINCY/MAGE-3 and pOTB7/HSP70 were used as template to amplify MAGE-3 and HSP70 gene by polymerase chain reaction (PCR). MAGE-3 upstream primer (containing Xho Ⅰ restriction site) and HSP70 downstream primer (containing Kpn Ⅰ restriction site) were used as template to amplify MAGE-3-HSP70 fusion gene fragments. The PCR products and empty plasmid pcDNA 3.1 (-) were digested by XhoⅠ and Kpn Ⅰ, ligated, then transformed competence E. coli DH5α. Positive clones were identified by restriction endonuclease digestion and sequencing. MAIN OUTCOME MEASURES: The identification of pcDNA3.1 (-)/MAGE-3-HSP70 fusion gene eukaryotic expression vector. RESULTS: Sequencing results showed that the MAGE-3 gene in the vector was in coincidence with the sequence registered in Gene Bank and the HSP70 had three synonymous mutations. CONCLUSION: MAGE-3-HSP70 fusion gene eukaryotic expression vector has been constructed successfully.

Heat Shock Protein 70/MAGE-3 Fusion Protein Vaccine Can Enhance Cellular and Humoral Immune Responses to MAGE-3 in Vivo.

Heat Shock Protein 70 / MAGE-1 Tumor Vaccine Can Enhance the Potency of MAGE-1–specific Cellular Immune Responses in Vivo

Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses

Gas‑filled Ultrasound Microbubbles Enhance the Immunoactivity of the HSP70‑MAGEA1 Fusion Protein Against MAGEA1‑expressing Tumours

Vaccination with A Dna Vaccine Based on Human Psca and Hsp70 Adjuvant Enhances the Antigen-Specific Cd8(+) T-Cell Response and Inhibits the Psca(+) Tumors Growth in Mice

Construction and Identification of Eukaryotic Expression Vector of MAGE-3-HSP70 Fusion Gene

Construction,expression and purification of a fusion gene of MAGE-n peptide with human heat shock protein 70

Fusion Proteins of Hsp70 with Tumor-Associated Antigen Acting As A Potent Tumor Vaccine and the C-Terminal Peptide-Binding Domain of Hsp70 Being Essential in Inducing Antigen-Independent Anti-Tumor Response in Vivo

Heat Shock Fusion Protein Induces Both Specific And Nonspecific Anti-Tumor Immunity

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

The Anti-Tumor Immune Response Induced by A Combination of Mage-3/Mage-N-Derived Peptides

Heterologous Expression of FMDV Immunodominant Epitopes and HSP70 in P. Pastoris and the Subsequent Immune Response in Mice

Establishment of antigen MAGE-3 gene vaccine and primary study of its immune activity

The Basic Study and Purification Strategy of MAGE-1/MAGE-3/Heat Shock Protein 70 Fusion Protein Tumor Vaccine

Potent antitumor effect elicited by superantigen-linked tumor cells transduced with heat shock protein 70 gene.

Recent Advances in Heat Shock Protein-Based Cancer Vaccines

Fusion Protein of ATPase Domain of Hsc70 with TRP2 Acting As a Tumor Vaccine Against B16 Melanoma.

High cell-density fermentation of engineered E.coli and antitumor immunity of recombinant human MAGE3/HSP70 in vivo

Mycobacterium Tuberculosis Heat Shock Protein 70 Enhances Immunization Respond of the Gene Vaccine Against Hepatocellular Carcinoma-Associated Antigens 661

Anti-gastric cancer immunity of MAGE-3 retrogen-transfected dendritic cells

The Fusion Protein of Hsp65 with Tandem Repeats of Beta-Hcg Acting As A Potent Tumor Vaccine in Suppressing Hepatocarcinoma